On January 22, European Health Commissioner Stella Kyriakides announced that the British-Swedish pharmaceutical company AstraZeneca would delay stipulated vaccine supplies to EU countries, while deliveries to the UK continue. Brussels temporally banned vaccine exports, as 13 percent of Britons have already been jabbed compared to 2 percent in EU.